|
|
|
|
| 1953–199? | 199?–2012 | 2012–2023 | 2023–present |
Janssen Pharmaceutica[]
1953–199?[]
199?–2012[]
|
UNKNOWN YEAR |
2012–2023[]
_stacked_tagline_variant.svg "Janssen (2012) stacked tagline variant.svg (255 KB)")
Stacked tagline variant
_horizontal_tagline_variant.svg "Janssen (2012) horizontal tagline variant.svg (70 KB)")
Horizontal tagline variant
Johnson & Johnson Innovative Medicine[]
2023–present[]
Shorthand variant
External links[]
| J&J Innovative Medicine Subsidiaries: Actelion | ALZA Corporation | Cilag | Crucell | J&J Pharmaceutical Research and Development | Ortho-McNeil Pharmaceutical | Tibotec J&J MedTech Former assets: 1Johnson & Johnson retained 9.5% shares in Kenvue, its former consumer health unit.  |